Movano Price to Free Cash Flow Ratio 2020-2024 | MOVE
Historical price to free cash flow ratio values for Movano (MOVE) since 2020.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Movano Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-05-15 | 1.04 | 0.00 | |
| 2024-12-31 | 5.40 | $-3.74 | 0.00 |
| 2024-09-30 | 5.39 | $-4.96 | 0.00 |
| 2024-06-30 | 4.13 | $-5.50 | 0.00 |
| 2024-03-31 | 6.17 | $-7.20 | 0.00 |
| 2023-12-31 | 11.72 | $-8.52 | 0.00 |
| 2023-09-30 | 16.35 | $-9.06 | 0.00 |
| 2023-06-30 | 16.35 | $-10.64 | 0.00 |
| 2023-03-31 | 18.45 | $-11.12 | 0.00 |
| 2022-12-31 | 19.50 | $-11.35 | 0.00 |
| 2022-09-30 | 41.25 | $-12.75 | 0.00 |
| 2022-06-30 | 35.85 | $-11.35 | 0.00 |
| 2022-03-31 | 40.65 | $-4.67 | 0.00 |
| 2021-12-31 | 57.00 | $-9.55 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.001B |
| Movano Inc. is a health technology company. It engages in designing devices which empower individuals to optimize their health in order to prevent and better manage chronic diseases. Movano Inc. is based in PLEASANTON, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.096B | 54.00 |
| Hims & Hers Health (HIMS) | United States | $13.681B | 142.14 |
| Tempus AI (TEM) | United States | $11.156B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.596B | 71.81 |
| IRhythm Technologies (IRTC) | United States | $4.484B | 0.00 |
| Privia Health (PRVA) | United States | $2.963B | 202.50 |
| Enovis (ENOV) | United States | $2.069B | 11.53 |
| Schrodinger (SDGR) | United States | $1.747B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.691B | 0.00 |
| Phreesia (PHR) | United States | $1.537B | 0.00 |
| Omnicell (OMCL) | United States | $1.346B | 23.74 |
| Azenta (AZTA) | United States | $1.233B | 57.32 |
| 10x Genomics (TXG) | United States | $1.115B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.517B | 154.50 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Claritev (CTEV) | United States | $0.435B | 0.00 |
| Standard BioTools (LAB) | United States | $0.406B | 0.00 |
| TruBridge (TBRG) | United States | $0.372B | 825.00 |
| Health Catalyst (HCAT) | United States | $0.291B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.205B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.146B | 0.00 |
| Pulmonx (LUNG) | United States | $0.131B | 0.00 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| MDxHealth SA (MDXH) | Belgium | $0.084B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.083B | 0.00 |
| Outset Medical (OM) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |